Cornerstone Advisors (Washington)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-225	Closed	-$1K	–	928
2017 Q1	$1K	Buy	+225	New	+$554	﹤0.01%	891
2016 Q3	–	Sell	-450	Closed	-$1K	–	939
2016 Q2	$1K	Hold	450	–	–	﹤0.01%	842
2016 Q1	$2K	Hold	450	–	–	﹤0.01%	770
2015 Q4	$4K	Hold	450	–	–	﹤0.01%	626
2015 Q3	$4K	Buy	+450	New	+$4.15K	﹤0.01%	619

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Cornerstone Advisors (Washington)'s INFI Position: Q2 2017 in Review

Cornerstone Advisors (Washington) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2017, closing a stake of 225 shares — an estimated $1K sold.

Cornerstone Advisors (Washington) first reported a position in INFI in Q3 2015 and held it in 5 quarters. The position peaked at $4K in Q4 2015. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

Cornerstone Advisors (Washington) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Cornerstone Advisors (Washington) sold 225 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1K.
Cornerstone Advisors (Washington) first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
Cornerstone Advisors (Washington)'s Infinity Pharmaceuticals, Inc. position peaked at $4K in Q4 2015.
74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q2 2017, filed 25 Jul 2017.